← Back to graph
Supplement

huperzine A sustained release

Selected indexed studies

  • Poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)-based microspheres as a sustained platform for Huperzine A delivery for alzheimer's disease therapy. (Int J Biol Macromol, 2024) [PMID:39447780]
  • Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies. (Int J Pharm, 2007) [PMID:16987624]
  • Administration of Huperzine A microspheres ameliorates myocardial ischemic injury via α7nAChR-dependent JAK2/STAT3 signaling pathway. (Eur J Pharmacol, 2023) [PMID:36563953]

_Worker-drafted node — pending editorial review._

Connections

huperzine A sustained release protects against

huperzine A sustained release helps

Sources

Local graph